Nostrum Biodiscovery
Barcelona
About Nostrum Biodiscovery
Nostrum is a biotech company working together with several major pharmaceutical companies in Europe and the US and has a wide knowledge of the requirements of pharmaceutical companies working in rational drug design. Nostrum advantages are its technologies, allowing the saving of costs and the acceleration of the whole process. Secondly, the level of calculation and prediction capacity by computation, which directly impacts research reliability. Lastly, the team experience and the research excellence which has been strongly demonstrated by the internationally-recognized institutions that support this project for years now.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $781.5K
- Funding stage: Seed
- Last round: Seed (Jan 2017)
- Website: nostrumbiodiscovery.com
- Phone: 0034696766027
Industries & Categories
Artificial Intelligence (AI), Bioinformatics, Biotechnology, Life Science, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/nostrum-biodiscovery-97579 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.